Medifast (MED) Shares Outstanding (Diluted Average) (2010 - 2026)

Medifast (MED) has 17 years of Shares Outstanding (Diluted Average) data on file, last reported at $11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 0.53% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (up 0.53% YoY), and the FY2025 full-year result was $11.0 million, changed 0.16% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $11.0 million, roughly flat from $11.0 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $11.6 million in Q1 2022 and bottomed at $10.9 million in Q1 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $11.0 million (2024), against an average of $11.1 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) declined 6.35%; it then gained 0.71% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $11.3 million in 2022, then decreased by 3.15% to $10.9 million in 2023, then rose by 0.38% to $11.0 million in 2024, then gained by 0.16% to $11.0 million in 2025, then rose by 0.23% to $11.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.0 million (Q1 2026), $11.0 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.

Peer Comparison